AAAAAA

   
Results: 1-10 |
Results: 10
IV IRON THERAPY IS REQUIRED FOR COMPLETE EPOGEN (EPO) EFFECT
Authors: DUNN I CALDERONE PG SHRIVASTAVA D
Citation: I. Dunn et al., IV IRON THERAPY IS REQUIRED FOR COMPLETE EPOGEN (EPO) EFFECT, Journal of the American Society of Nephrology, 8, 1997, pp. 321-321
COMPARISON OF SURVIVAL IN END-STAGE RENAL-DISEASE (ESRD) DIALYSIS PATIENTS (PTS) ON DIFFERENT DIALYSIATE MEMBRANE
Authors: SHRIVASTAVA D KUMAR G LODHI H SOLIMAN S YOUSUFUDDIN M MALLICK A HAMEED M AHMED I KHAN J SINGH M SHEIN L ANKOBIAH W DUNN I
Citation: D. Shrivastava et al., COMPARISON OF SURVIVAL IN END-STAGE RENAL-DISEASE (ESRD) DIALYSIS PATIENTS (PTS) ON DIFFERENT DIALYSIATE MEMBRANE, Journal of the American Society of Nephrology, 8, 1997, pp. 1337-1337
IMPACT OF EDUCATION ON COMPLIANCE IN A SPECIAL GROUP OF TB-INFECTED PATIENTS - A PROSPECTIVE-STUDY
Authors: SHRIVASTAVA D PERIYAKOIL V KAMSTRA D KAPRE S GUNDERSON B
Citation: D. Shrivastava et al., IMPACT OF EDUCATION ON COMPLIANCE IN A SPECIAL GROUP OF TB-INFECTED PATIENTS - A PROSPECTIVE-STUDY, Journal of investigative medicine, 44(1), 1996, pp. 189-189
MULTIPLE ORGAN DYSFUNCTION SYNDROME SECONDARY TO DISSEMINATED STRONGYLOIDIASIS - A REPORT OF 3 CASES
Authors: SHRIVASTAVA D KALRA JS KAPRE S
Citation: D. Shrivastava et al., MULTIPLE ORGAN DYSFUNCTION SYNDROME SECONDARY TO DISSEMINATED STRONGYLOIDIASIS - A REPORT OF 3 CASES, Journal of investigative medicine, 44(1), 1996, pp. 191-191
A RARE CAUSE OF MASSIVE CARDIOMEGALY
Authors: SHRIVASTAVA D DHARAWAT R KAPRE S SOLANKI KK
Citation: D. Shrivastava et al., A RARE CAUSE OF MASSIVE CARDIOMEGALY, Journal of investigative medicine, 44(1), 1996, pp. 196-196
FACTORS AFFECTING MORTALITY IN DIABETIC-PATIENTS (PTS) UNDERGOING MAINTENANCE HEMODIALYSIS (MD)
Authors: SHRIVASTAVA D GILL R NAWAZ M KENNEDY D KUMAR S DEJESUS D KHAN J SHEIN L CALDERONE P DUNN I
Citation: D. Shrivastava et al., FACTORS AFFECTING MORTALITY IN DIABETIC-PATIENTS (PTS) UNDERGOING MAINTENANCE HEMODIALYSIS (MD), Journal of the American Society of Nephrology, 6(3), 1995, pp. 562-562
THE EFFICACY OF ERYTHROPOIETIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED END-STAGE RENAL-DISEASE PATIENTS TREATED BY MAINTENANCE HEMODIALYSIS
Authors: SHRIVASTAVA D RAO TKS SINERT R KHURANA E LUNDIN AP FRIEDMAN EA
Citation: D. Shrivastava et al., THE EFFICACY OF ERYTHROPOIETIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED END-STAGE RENAL-DISEASE PATIENTS TREATED BY MAINTENANCE HEMODIALYSIS, American journal of kidney diseases, 25(6), 1995, pp. 904-909
PREVALENCE AND FACTORS AFFECTING PROGRESSION OF RENAL-DISEASE IN HIV+PATIENTS (PTS)
Authors: SHRIVASTAVA D ADAMS G QUERASHI N RAO TKS KACHUR F SHEIN I DUNN I
Citation: D. Shrivastava et al., PREVALENCE AND FACTORS AFFECTING PROGRESSION OF RENAL-DISEASE IN HIV+PATIENTS (PTS), Journal of the American Society of Nephrology, 5(3), 1994, pp. 360-360
RESPONSE TO ERYTHROPOIETIN (EPO) IN HIV-LINE SERUM EPO LEVELS( ESRD PATIENTS (PTS) CORRELATES WITH BASE)
Authors: SHRIVASTAVA D RAO TKS LUNDIN AP FRIEDMAN EA
Citation: D. Shrivastava et al., RESPONSE TO ERYTHROPOIETIN (EPO) IN HIV-LINE SERUM EPO LEVELS( ESRD PATIENTS (PTS) CORRELATES WITH BASE), Journal of the American Society of Nephrology, 5(3), 1994, pp. 477-477
SALVAGE OF CLOTTED JUGULAR-VEIN HEMODIALYSIS CATHETERS
Authors: SHRIVASTAVA D LUNDIN AP DOSUNMU B RAO TKS BEYER MM FRIEDMAN EA
Citation: D. Shrivastava et al., SALVAGE OF CLOTTED JUGULAR-VEIN HEMODIALYSIS CATHETERS, Nephron, 68(1), 1994, pp. 77-79
Risultati: 1-10 |